Annual EBITDA
-$8.81 M
+$663.60 K+7.00%
June 30, 2024
Summary
- As of February 22, 2025, INBS annual EBITDA is -$8.81 million, with the most recent change of +$663.60 thousand (+7.00%) on June 30, 2024.
- During the last 3 years, INBS annual EBITDA has fallen by -$2.84 million (-47.67%).
- INBS annual EBITDA is now -222.12% below its all-time high of -$2.74 million, reached on June 1, 2020.
Performance
INBS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$1.94 M
+$433.70 K+18.30%
December 31, 2024
Summary
- As of February 22, 2025, INBS quarterly EBITDA is -$1.94 million, with the most recent change of +$433.70 thousand (+18.30%) on December 31, 2024.
- Over the past year, INBS quarterly EBITDA has dropped by -$282.10 thousand (-17.06%).
- INBS quarterly EBITDA is now -4141.13% below its all-time high of $47.90 thousand, reached on December 31, 2022.
Performance
INBS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$9.37 M
-$282.10 K-3.10%
December 31, 2024
Summary
- As of February 22, 2025, INBS TTM EBITDA is -$9.37 million, with the most recent change of -$282.10 thousand (-3.10%) on December 31, 2024.
- Over the past year, INBS TTM EBITDA has increased by +$2.67 million (+22.20%).
- INBS TTM EBITDA is now -1139.89% below its all-time high of -$756.10 thousand, reached on March 1, 2018.
Performance
INBS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
INBS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.0% | -17.1% | +22.2% |
| 3 y3 years | -47.7% | -4141.1% | -104.2% |
| 5 y5 years | -30.9% | -4141.1% | -104.2% |
INBS EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -47.7% | +7.0% | -4141.1% | +67.0% | -104.2% | +22.2% |
| 5 y | 5-year | -222.1% | +7.0% | -4141.1% | +67.0% | -288.9% | +22.2% |
| alltime | all time | -222.1% | +7.0% | -4141.1% | +67.0% | -1139.9% | +22.2% |
Intelligent Bio Solutions EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | -$1.94 M(-18.3%) | -$9.37 M(+3.1%) |
| Sep 2024 | - | -$2.37 M(-3.4%) | -$9.09 M(+3.2%) |
| Jun 2024 | -$8.81 M(-7.0%) | -$2.45 M(-6.2%) | -$8.81 M(+0.1%) |
| Mar 2024 | - | -$2.62 M(+58.2%) | -$8.80 M(-27.0%) |
| Dec 2023 | - | -$1.65 M(-20.8%) | -$12.05 M(+16.4%) |
| Sep 2023 | - | -$2.09 M(-14.5%) | -$10.35 M(+9.2%) |
| Jun 2023 | -$9.47 M(+13.8%) | -$2.44 M(-58.4%) | -$9.47 M(+3.9%) |
| Mar 2023 | - | -$5.87 M(<-9900.0%) | -$9.12 M(+98.6%) |
| Dec 2022 | - | $47.90 K(-103.9%) | -$4.59 M(-43.3%) |
| Sep 2022 | - | -$1.21 M(-41.8%) | -$8.10 M(-2.7%) |
| Jun 2022 | -$8.33 M | - | - |
| Jun 2022 | - | -$2.09 M(+55.6%) | -$8.33 M(+17.5%) |
| Mar 2022 | - | -$1.34 M(-61.3%) | -$7.09 M(-20.1%) |
| Dec 2021 | - | -$3.46 M(+140.9%) | -$8.87 M(+38.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$1.44 M(+69.6%) | -$6.41 M(+7.5%) |
| Jun 2021 | -$5.97 M(+118.1%) | -$847.90 K(-72.9%) | -$5.97 M(+8.4%) |
| Mar 2021 | - | -$3.12 M(+211.3%) | -$5.51 M(+128.4%) |
| Dec 2020 | - | -$1.00 M(+1.3%) | -$2.41 M(-22.5%) |
| Sep 2020 | - | -$991.10 K(+156.0%) | -$3.11 M(+13.7%) |
| Jun 2020 | -$2.74 M(-59.4%) | -$387.20 K(+1244.4%) | -$2.74 M(-49.1%) |
| Mar 2020 | - | -$28.80 K(-98.3%) | -$5.37 M(-20.9%) |
| Dec 2019 | - | -$1.70 M(+176.9%) | -$6.79 M(+33.5%) |
| Sep 2019 | - | -$615.30 K(-79.7%) | -$5.08 M(-14.9%) |
| Jun 2019 | -$6.73 M(+46.2%) | -$3.02 M(+109.5%) | -$5.98 M(+26.0%) |
| Mar 2019 | - | -$1.44 M(-4.1%) | -$4.74 M(+17.0%) |
| Sep 2018 | - | -$1.51 M(-16.0%) | -$4.06 M(+59.1%) |
| Jun 2018 | -$4.60 M | -$1.79 M(+137.2%) | -$2.55 M(+237.2%) |
| Mar 2018 | - | -$756.10 K | -$756.10 K |
FAQ
- What is Intelligent Bio Solutions annual EBITDA?
- What is the all time high annual EBITDA for Intelligent Bio Solutions?
- What is Intelligent Bio Solutions annual EBITDA year-on-year change?
- What is Intelligent Bio Solutions quarterly EBITDA?
- What is the all time high quarterly EBITDA for Intelligent Bio Solutions?
- What is Intelligent Bio Solutions quarterly EBITDA year-on-year change?
- What is Intelligent Bio Solutions TTM EBITDA?
- What is the all time high TTM EBITDA for Intelligent Bio Solutions?
- What is Intelligent Bio Solutions TTM EBITDA year-on-year change?
What is Intelligent Bio Solutions annual EBITDA?
The current annual EBITDA of INBS is -$8.81 M
What is the all time high annual EBITDA for Intelligent Bio Solutions?
Intelligent Bio Solutions all-time high annual EBITDA is -$2.74 M
What is Intelligent Bio Solutions annual EBITDA year-on-year change?
Over the past year, INBS annual EBITDA has changed by +$663.60 K (+7.00%)
What is Intelligent Bio Solutions quarterly EBITDA?
The current quarterly EBITDA of INBS is -$1.94 M
What is the all time high quarterly EBITDA for Intelligent Bio Solutions?
Intelligent Bio Solutions all-time high quarterly EBITDA is $47.90 K
What is Intelligent Bio Solutions quarterly EBITDA year-on-year change?
Over the past year, INBS quarterly EBITDA has changed by -$282.10 K (-17.06%)
What is Intelligent Bio Solutions TTM EBITDA?
The current TTM EBITDA of INBS is -$9.37 M
What is the all time high TTM EBITDA for Intelligent Bio Solutions?
Intelligent Bio Solutions all-time high TTM EBITDA is -$756.10 K
What is Intelligent Bio Solutions TTM EBITDA year-on-year change?
Over the past year, INBS TTM EBITDA has changed by +$2.67 M (+22.20%)